戻る
Biocure Technology Inc (BICTF) 財務
BICTF 株価推移チャート
BICTF 財務
Biocure Technology Inc
$0.01
0%
$0
終値： Mar 24, 16:00:00 GMT-4
$0.01
0%
$0
アフターマーケット：Mar 24, 20:00:00 GMT-4
主要データ
前終値
$0.01
始値
$0.01
当日レンジ
$0.01 - $0.07
52週レンジ
$0.0012 - $0.63
取引高
1.0K
平均取引高
0
配当利回り
--
1株当たり利益(TTM)
-0.02
時価総額
$154.4K
BIOCURE TECHNOLOGY INCとは何ですか？
Biocure Technology, Inc. engages in the development and commercialization of biosimilar products. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2008-03-27. The firm specializes in the development and commercialization of its own CAR T-cell therapy, targeting Chronic lymphocytic leukemia and solid tumor cancers. Additionally, the Company is developing biosimilar technologies for cancer treatment. The Company’s products include Interferon Beta, Ranibizumab and PEG-Filgrastim.